Video – Clinical Trial Results

Robin Nijveldt and C. Michael Gibson Discuss: iMODERN:iFR- vs. Cardiac MRI-Guided Revascularization of Non-Culprit Lesions in STEMI

October 28, 2025

Disclosures: TBD

Shamir R. Mehta and C. Michael Gibson Discuss: STRIVE:Low-Dose r-tPA vs. Placebo in STEMI With Large Thrombus Burden

October 28, 2025

Disclosures: TBD

Ruben de Winter and C. Michael Gibson Discuss: PROCTOR:Native Vessel vs. SVG PCI in Patients With Prior CABG

October 28, 2025

Disclosures: TBD

Matthias Bossard and C. Michael Gibson Discuss: VICTORY:Intravascular Lithotripsy vs. Super-High-Pressure PTCA in Calcified and Refractory Coronary Lesions

October 26, 2025

Disclosures: TBD

Donald Cutlip and C. Michael Gibson Discuss: SELUTION4ISR: Sirolimus-Eluting DCB vs. DES or Balloon Angioplasty for In-Stent Restenosis

October 26, 2025

Disclosures: TBD

Christian M. Spaulding and C. Michael Gibson Discuss: SELUTION DeNovo: Sirolimus-Eluting DCB vs. DES in De Novo Coronary Lesions

October 26, 2025

Disclosures: TBD

Dr. Hofmann and Dr. Gibson discuss HELP-MI SWEDEHEART trial

September 5, 2025

Disclosures: TBD

Dr. Adam Castano and Dr. C. Michael Gibson discuss: ACT-EARLY, a Phase 3 Study – Clinical Trial Results

May 12, 2025

Disclosures: Sponsored by BridgeBio Pharma, Inc

#ACC2025 Antithrmbotic / Antiplatelet Wrap Up:

April 11, 2025

Dr. Bhatt and I discuss ticagrelor reversal using bentracimab from the REVERSE-IT trial, as well as comparable efficacy and safety […]

Dr. Xiaojie Xie and Dr. C. Michael Gibson discuss: Efficacy And Safety Of SHR-1918, An Angiopoietin-like 3 Monoclonal Antibody, In Combination With Lipid-lowering Therapy In Patients With Suboptimally Controlled Hyperlipidemia: A Multicenter, Randomized, Double Blind, Placebo-controlled Phase 2 Trial

March 31, 2025

Disclosures: TBD